An 11-amino-acid synthetic peptide (cibinetide, CAS 1208243-50-8) derived from the B-helix of erythropoietin. Agonizes the tissue-protective beta-common receptor / EPOR heteroreceptor while lacking affinity for the classical EPO homodimer, dissociating EPO's anti-inflammatory and neuroprotective activity from its erythropoietic activity. Developed by Araim Pharmaceuticals; evaluated in Phase 2 for sarcoidosis small-fiber neuropathy and diabetic neuropathic pain. Not FDA-approved.
For research purposes only. Not medical advice.
Ruo Bio currently lists ARA-290 at $3.40/mg, the lowest indexed price across 12 tracked research peptide vendors.
ARA-290 ranges from $3.40/mg to $7.00/mg across 18 listings from 12 research peptide vendors, normalized to USD per milligram and refreshed daily.
12 research peptide vendors currently list ARA-290 on PeptideScouter, with 10 in stock right now. We track 18 active listings across size and kit variants.
ARA-290's CAS Registry Number is 1208243-50-8.